| Financial Year |
March 31 2023 |
| Monetary Funds |
1,421,003,405.46 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
16,735,538.63 |
| Accounts Receivable |
947,951,305.51 |
| Advances to Suppliers |
132,475,568.14 |
| Other Receivables |
61,782,355.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
764,301,940.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
93,664,863.75 |
| Total Current Assets |
5,444,693,450.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
598,025,204.27 |
| Long-term Equity Investment |
65,014,899.71 |
| Investment Properties |
155,372,082.27 |
| Fixed Assetes |
440,304,867.42 |
| Under-construction Projects |
4,853,608.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,591,726,796.22 |
| R&D expenses |
-- |
| Goodwill |
1,799,586.07 |
| Long-Term Deferred and Prepaid Expenses |
37,621,060.01 |
| Deferred Income Tax Assets |
114,985,045.20 |
| Other Non-Current Assets |
2,757,716.49 |
| Sub-Total of Non-Current Assets |
4,043,478,147.06 |
| Total Assets |
9,488,171,597.38 |
| Short-Term Loans |
1,005,809,722.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
247,700,000.00 |
| Accounts Payable |
1,528,133,589.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,605,825.35 |
| Taxes Payable |
138,027,165.88 |
| Interest Payable |
28,875.00 |
| Dividend Payable |
5,900,000.00 |
| Other payables |
127,646,740.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
255,822,729.50 |
| Other Current Liabilities |
68,693,629.57 |
| Sub-Total of Current Liabilities |
3,941,419,253.62 |
| Long-term Loans |
1,313,761,985.42 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
398,089.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,461,395,554.91 |
| Total Liabilities |
5,402,814,808.53 |
| Paid-In Capital(Or Share Stock) |
863,943,140.00 |
| Capital Surplus |
2,760,769,277.29 |
| Surplus Reserve |
35,255,646.64 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
189,858,528.72 |
| Minority Stockholder's Interest |
228,602,007.88 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,856,754,780.97 |
| Owner's Equity（Stockholder's Equity） |
4,085,356,788.85 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,488,171,597.38 |
